logo

Eloxx Pharmaceuticals, Inc. (ELOX)



Trade ELOX now with
  Date
  Headline
9/15/2022 7:41:31 AM Eloxx Pharma Says Phase 2 Study Of ELX-02 With Ivacaftor In Class 1 Cystic Fibrosis Fails To Meet Endpoints
11/17/2021 7:27:26 AM Eloxx Pharma Reports Positive Topline Results From Monotherapy Arms Of Phase 2 Trial Of ELX-02 In Class 1 CF
4/1/2021 7:52:49 AM Eloxx Pharmaceuticals Buys Zikani Therapeutics